301089 fundamentals
An in-depth look to TUOXIN PHARM GP CO operating, investing, and financing activities
301089 free cash flow for Q3 24 is 25.95 M CNY. For 2023, 301089 free cash flow was -151.7 M CNY and operating cash flow was 33.52 M CNY.
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CNY
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM